Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2026-06-15 @ 10:00 AM
Study NCT ID:
NCT05640804
Status:
COMPLETED
Last Update Posted:
2022-12-08
First Post:
2022-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Bioequivalence Study of Dasatinib Tablet
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia, Myelogenous, Chronic | View |
Keywords: